| pubmed-article:17666345 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17666345 | lifeskim:mentions | umls-concept:C0036536 | lld:lifeskim |
| pubmed-article:17666345 | lifeskim:mentions | umls-concept:C0036537 | lld:lifeskim |
| pubmed-article:17666345 | lifeskim:mentions | umls-concept:C0225336 | lld:lifeskim |
| pubmed-article:17666345 | lifeskim:mentions | umls-concept:C0003018 | lld:lifeskim |
| pubmed-article:17666345 | lifeskim:mentions | umls-concept:C0245514 | lld:lifeskim |
| pubmed-article:17666345 | lifeskim:mentions | umls-concept:C1418776 | lld:lifeskim |
| pubmed-article:17666345 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:17666345 | lifeskim:mentions | umls-concept:C1980011 | lld:lifeskim |
| pubmed-article:17666345 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:17666345 | pubmed:dateCreated | 2007-8-1 | lld:pubmed |
| pubmed-article:17666345 | pubmed:abstractText | To investigate the effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand on angiotensin II (AngII)-induced endothelin-1 (ET-1) and NO secretion by endothelial cells in comparison with AngII type I receptor (AT1R) antagonist losartan, so as to reveal the relationship between PPAR gamma and essential hypertension. | lld:pubmed |
| pubmed-article:17666345 | pubmed:language | chi | lld:pubmed |
| pubmed-article:17666345 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17666345 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17666345 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17666345 | pubmed:issn | 1673-4254 | lld:pubmed |
| pubmed-article:17666345 | pubmed:author | pubmed-author:HoffDD | lld:pubmed |
| pubmed-article:17666345 | pubmed:author | pubmed-author:ZhouJuanJ | lld:pubmed |
| pubmed-article:17666345 | pubmed:author | pubmed-author:WangShi-jieSJ | lld:pubmed |
| pubmed-article:17666345 | pubmed:author | pubmed-author:LiYong-qinYQ | lld:pubmed |
| pubmed-article:17666345 | pubmed:author | pubmed-author:NiuXiao-linXL | lld:pubmed |
| pubmed-article:17666345 | pubmed:author | pubmed-author:WangCong-xiaC... | lld:pubmed |
| pubmed-article:17666345 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17666345 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:17666345 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17666345 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17666345 | pubmed:pagination | 1030-3 | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:meshHeading | pubmed-meshheading:17666345... | lld:pubmed |
| pubmed-article:17666345 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17666345 | pubmed:articleTitle | [Peroxisome proliferator-activated receptor activator troglitazone inhibits angiotensin II-stimulated secretion of vasoactive factors by endothelial cells]. | lld:pubmed |
| pubmed-article:17666345 | pubmed:affiliation | Department of Cardiology, Second Hospital of Xi'an Jiaotong University, and Department of Pathophysiology, Xi'an Jiaotong University, China. | lld:pubmed |
| pubmed-article:17666345 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17666345 | pubmed:publicationType | English Abstract | lld:pubmed |
